Displaying items 109-120 of 1187
» View latimes.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-99
•
Next >
-
Los Angeles goes blue for prostate cancer awareness
L.A. NOWBlue light prostate cancer: Los Angeles City Hall and other area landmarks will be bathed in blue light starting Friday to raise awareness about prostate cancer, a major health concern that men often ignore, officials said.... -
Was Nobel prizewinning poet Pablo Neruda poisoned?
Jacket CopyAn investigation into the death of Chilean poet Pablo Neruda may lead to his exhumation.... -
Alejandro Stephens dies at 67; controversial labor leader
Alejandro Stephens, a longtime Los Angeles County union leader who went to prison for misusing funds from a labor nonprofit, died June 13 of complications of prostate cancer. He was 67.
Stephens, who worked for the county for more than three decades...Tags: Crimes, Political Corruption, Career and Workplace, Marketing, Crime, Law and Justice
-
Texas fire: Chemical plant processes toxics, produces pesticide
GreenspaceThe plant, about 30 miles north of Dallas, also is listed as a pesticide producer, and reportedly mixes chemicals used in agriculture and the petroleum industry, including fluids for hydraulic fracturing.... -
A cancer cocktail's edge
Special to the Los Angeles TimesEven if a vaccine produces an appropriate cancer-attacking immune response, it still may not be enough to achieve clinical benefit, especially in patients with very advanced disease. This could be because the ability of large tumors to suppress the...Tags: Crime, Law and Justice, Pharmaceuticals, Immune System, Diseases and Illnesses, Trials
-
Coming soon in the medical arsenal against cancer: vaccines
Los Angeles Times Staff WriterIt's a deceptively simple idea: What if doctors could recruit the body's own immune system to fight cancer? The complexities of the immune system have kept this from becoming reality, until now. Three cancer vaccines -- for prostate cancer, melanoma and...Tags: Donald Morton, Pharmaceuticals, Science and Technology, Diseases and Illnesses, University of California, Los Angeles
-
Cancer tests are priceless
Special to the Los Angeles TimesAre you due for a cancer screening test? Don't let cost stand in the way. Yes, it would be easier to schedule such tests if you have insurance, a regular doctor who can refer you to screenings and money in your checking account to foot the bill. But...Tags: Diseases and Illnesses, University of California, Los Angeles, Insurance, Computer Networking and Internet, Breast Cancer
-
DNA referees
Your life story depends upon a combination of the DNA you're stuck with plus your environment, including all the little choices and events that happen over that lifetime.
But in recent years, researchers have discovered that, while DNA lays out the...Tags: Genes and Chromosomes, DNA, Pharmaceuticals, Durham (Durham, North Carolina), Science and Technology
-
Cancer screening: What could it hurt? A lot, actually
It seemed like a good idea at the time.
In 1984, Japan began screening the urine of 6-month-old infants for neuroblastoma, the most common type of solid tumor in young children. The test was simple and could show signs of cancer long before clinical...Tags: University of Texas at Austin, Diseases and Illnesses, Science and Technology, Advice Columns and Columnists, Sports
-
Many men with low-risk prostate cancer overtreated, study finds
About three-quarters of men with low-risk prostate tumors that can safely be ignored for months or years receive aggressive treatment, despite the risk of complications, researchers reported Monday. The findings, published in the Archives of Internal...Tags: Physical Therapists, Prostate, Diseases and Illnesses, Internists, Radiation Therapy
-
Therapies' benefits unclear
Los Angeles TimesIn a quest to look younger, be healthier and feel more vital later in life, increasing numbers of men, just like Jeffry Life, are turning to testosterone and human growth hormone. Use of both hormones is controversial. Read on: Testosterone: "Older men ....Tags: Prostate, IMS Health Incorporated, Brain, Physical Conditions, David Geffen School of Medicine
-
Recommendations for cancer screening are under review
You'd think there could be no downside to widespread screening for cancer. But that's not always the case. Studies on Pap smears, for example, show that atypical cells can disappear if they're left alone, while interventions can cause scarring and...Tags: Diseases and Illnesses, Health and Safety at School, Colon Cancer, National or Ethnic Minorities, Breast Cancer
Sep 12, 2011
| Los Angeles Times
Jun 6, 2011
| Los Angeles Times
Jun 20, 2011
|Story| Los Angeles Times
Oct 3, 2011
| Los Angeles Times
Jul 6, 2009
|Story| Los Angeles Times
Jul 6, 2009
|Story| Los Angeles Times
Aug 31, 2009
|Story| Los Angeles Times
May 3, 2010
|Story| Los Angeles Times
Nov 21, 2009
|Story| Los Angeles Times
Jul 27, 2010
|Story| Los Angeles Times
Jan 18, 2010
|Story| Los Angeles Times
Dec 28, 2009
|Story| Los Angeles Times
